acc0851 |
S6 |
phosphorylation |
Ser235 |
rat |
Pituitary Tumor |
GH3 |
BEZ235 |
Associated |
4.0 |
26983879
|
acc0852 |
S6 |
phosphorylation |
Ser236 |
rat |
Pituitary Tumor |
GH3 |
BEZ235 |
Associated |
4.0 |
26983879
|
acc0853 |
mTOR |
phosphorylation |
Ser2448 |
rat |
Pituitary Tumor |
GH3 |
BEZ235 |
Associated |
4.0 |
26983879
|
acc0854 |
Akt |
phosphorylation |
Ser473 |
mouse |
Neuroblastoma |
TBJ |
Bortezomib |
Associated |
4.0 |
16670342
|
acc0855 |
Akt |
phosphorylation |
Ser473 |
mouse |
Neuroblastoma |
Neuro-2a |
Bortezomib |
Associated |
4.0 |
16670342
|
acc0856 |
AKT |
phosphorylation |
Ser473 |
human |
Leukemia |
MV4-11 |
Cabozantinib |
Associated |
4.0 |
30862120
|
acc0857 |
AKT |
phosphorylation |
Ser473 |
human |
Leukemia |
MV4-11 |
MK2206 |
Associated |
4.0 |
30862120
|
acc0858 |
Chk1 |
phosphorylation |
Ser345 |
mouse |
Skin Cancer |
SKH-1 mice |
Caffeine |
Associated |
4.0 |
18381462
|
acc0859 |
AKT |
phosphorylation |
Ser473 |
human |
Lung Cancer |
H82 |
Darifenacin |
Associated |
4.0 |
17440109
|
acc0860 |
ERK1 |
phosphorylation |
Thr202 |
human |
Lung Cancer |
H82 |
Darifenacin |
Associated |
4.0 |
17440109
|
acc0861 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Lung Cancer |
H82 |
Darifenacin |
Associated |
4.0 |
17440109
|
acc0862 |
ERK2 |
phosphorylation |
Thr185 |
human |
Lung Cancer |
H82 |
Darifenacin |
Associated |
4.0 |
17440109
|
acc0863 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Lung Cancer |
H82 |
Darifenacin |
Associated |
4.0 |
17440109
|
acc0864 |
beta-catenin |
phosphorylation |
Ser33 |
human |
Hepatocellular Carcinoma |
HuH-7 |
Canagliflozin |
Associated |
4.0 |
31142735
|
acc0865 |
beta-catenin |
phosphorylation |
Ser37 |
human |
Hepatocellular Carcinoma |
HuH-7 |
Canagliflozin |
Associated |
4.0 |
31142735
|
acc0866 |
beta-catenin |
phosphorylation |
Thr41 |
human |
Hepatocellular Carcinoma |
HuH-7 |
Canagliflozin |
Associated |
4.0 |
31142735
|
acc0867 |
beta-catenin |
phosphorylation |
Ser45 |
human |
Hepatocellular Carcinoma |
HuH-7 |
Canagliflozin |
Associated |
4.0 |
31142735
|
acc0868 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Pancreas Cancer |
PANC-1 |
Radiotherapy |
Impairing |
4.5 |
26887043
|
acc0869 |
AKT |
phosphorylation |
Ser473 |
human |
Melanoma |
A375 |
Chondroitin-4-sulfate (CHSA) |
Associated |
4.0 |
29547721
|
acc0870 |
AKT |
phosphorylation |
Ser473 |
human |
Melanoma |
SK-MEL-5 |
Chondroitin-4-sulfate (CHSA) |
Associated |
4.0 |
29547721
|
acc0871 |
AKT |
phosphorylation |
Thr308 |
human |
Melanoma |
A375 |
Chondroitin-4-sulfate (CHSA) |
Associated |
4.0 |
29547721
|
acc0872 |
AKT |
phosphorylation |
Thr308 |
human |
Melanoma |
SK-MEL-5 |
Chondroitin-4-sulfate (CHSA) |
Associated |
4.0 |
29547721
|
acc0873 |
PTEN |
phosphorylation |
Ser380 |
human |
Melanoma |
A375 |
Chondroitin-4-sulfate (CHSA) |
Associated |
4.0 |
29547721
|
acc0874 |
PTEN |
phosphorylation |
Ser380 |
human |
Melanoma |
SK-MEL-5 |
Chondroitin-4-sulfate (CHSA) |
Associated |
4.0 |
29547721
|
acc0875 |
PTEN |
phosphorylation |
Thr382 |
human |
Melanoma |
A375 |
Chondroitin-4-sulfate (CHSA) |
Associated |
4.0 |
29547721
|
acc0876 |
PTEN |
phosphorylation |
Thr382 |
human |
Melanoma |
SK-MEL-5 |
Chondroitin-4-sulfate (CHSA) |
Associated |
4.0 |
29547721
|
acc0877 |
PTEN |
phosphorylation |
Thr383 |
human |
Melanoma |
A375 |
Chondroitin-4-sulfate (CHSA) |
Associated |
4.0 |
29547721
|
acc0878 |
PTEN |
phosphorylation |
Thr383 |
human |
Melanoma |
SK-MEL-5 |
Chondroitin-4-sulfate (CHSA) |
Associated |
4.0 |
29547721
|
acc0879 |
AKT |
phosphorylation |
Tyr705 |
human |
Ovarian Cancer |
HEY |
Cisplatin |
Impairing |
5.0 |
31597912
|
acc0880 |
AKT |
phosphorylation |
Tyr705 |
human |
Ovarian Cancer |
SK-OV-3 |
Cisplatin |
Impairing |
5.0 |
31597912
|
acc0881 |
AKT |
phosphorylation |
Thr308 |
human |
Breast Cancer |
MCF7/MDR |
Cisplatin |
Impairing |
5.0 |
31006103
|
acc0882 |
AKT |
phosphorylation |
Ser473 |
human |
Ovarian Cancer |
ES-2 |
Goserelin |
Associated |
4.0 |
23684357
|
acc0883 |
AKT |
phosphorylation |
Ser473 |
human |
Ovarian Cancer |
SK-OV-3-ip |
Goserelin |
Associated |
4.0 |
23684357
|
acc0884 |
AKT |
phosphorylation |
Ser473 |
human |
Bladder Cancer |
J82 |
Cisplatin |
Impairing |
5.0 |
28178653
|
acc0885 |
AKT |
phosphorylation |
Ser473 |
human |
Bladder Cancer |
BIU-87 |
Cisplatin |
Impairing |
5.0 |
28178653
|
acc0886 |
FOXO3a |
phosphorylation |
Thr32 |
human |
Lung Cancer |
A549 |
Cisplatin |
Associated |
4.0 |
24814195
|
acc0887 |
PI3K |
phosphorylation |
Tyr458 |
human |
Lung Cancer |
A549 |
Cisplatin |
Associated |
4.0 |
24814195
|
acc0888 |
AKT |
phosphorylation |
Ser473 |
human |
Lung Cancer |
A549 |
Cisplatin |
Associated |
4.0 |
24814195
|
acc0889 |
Chk2 |
phosphorylation |
Thr68 |
human |
Testicular Cancer |
833K |
Cisplatin |
Associated |
4.0 |
20846399
|
acc0890 |
Chk2 |
phosphorylation |
Thr68 |
human |
Testicular Cancer |
SuSa |
Cisplatin |
Associated |
4.0 |
20846399
|
acc0891 |
AKT |
phosphorylation |
Ser473 |
human |
Gastric Cancer |
SGC7901 |
Cisplatin |
Impairing |
5.0 |
32058824
|
acc0892 |
ERK1 |
phosphorylation |
Thr202 |
human |
Osteosarcoma |
U2OS |
CQ-HES |
Associated |
4.0 |
28708385
|
acc0893 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Osteosarcoma |
U2OS |
CQ-HES |
Associated |
4.0 |
28708385
|
acc0894 |
ERK2 |
phosphorylation |
Thr185 |
human |
Osteosarcoma |
U2OS |
CQ-HES |
Associated |
4.0 |
28708385
|
acc0895 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Osteosarcoma |
U2OS |
CQ-HES |
Associated |
4.0 |
28708385
|
acc0896 |
AKT |
phosphorylation |
Ser473 |
human |
Osteosarcoma |
U2OS |
CQ-HES |
Associated |
4.0 |
28708385
|
acc0897 |
ERK1 |
phosphorylation |
Thr202 |
human |
Breast Cancer |
SK-BR-3 |
Curcumin + Tricostatin A |
Associated |
4.0 |
22290509
|
acc0898 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Breast Cancer |
SK-BR-3 |
Curcumin + Tricostatin A |
Associated |
4.0 |
22290509
|
acc0899 |
p38 |
phosphorylation |
Thr180 |
human |
Breast Cancer |
SK-BR-3 |
Curcumin + Tricostatin A |
Associated |
4.0 |
22290509
|
acc0900 |
p38 |
phosphorylation |
Thr180 |
human |
Breast Cancer |
435eB |
Curcumin + Tricostatin A |
Associated |
4.0 |
22290509
|